SEC Form 4 · accession 0001209191-16-133752
Patheon N.V. · PTHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gilles Cottier
Officer — President, Pharma Dev Svcs
Period of report
Jul 20, 2016
Accepted (ET)
Jul 22, 2016 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001643848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (Ordinary Shares)F1 | Jul 20, 2016 | A | 70,141 | $0.00 | A | 70,141 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options (Right to Buy)F2 | $21.00 | Jul 20, 2016 | A | 123,754 | A | — | Jul 20, 2026 | Ordinary Shares | 123,754 | 123,754 | D |
Explanation of responses
- F1The restricted stock units vest in three equal installments on each anniversary of January 11, 2016. Each restricted stock unit represents a contingent right to receive one ordinary share.
- F2The options vest in three equal installments on each anniversary of January 11, 2016.